Raymond James Financial Inc. Makes New $533,000 Investment in Denali Therapeutics Inc. (NASDAQ:DNLI)

Raymond James Financial Inc. purchased a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth quarter, Holdings Channel.com reports. The firm purchased 26,143 shares of the company’s stock, valued at approximately $533,000. Several other large investors have also recently made changes to their positions in the stock. Principal Financial Group Inc. […]